ID: ALA5291412

Max Phase: Preclinical

Molecular Formula: C12H14ClN

Molecular Weight: 207.70

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C(C)(C)CC#N)c(Cl)c1

Standard InChI:  InChI=1S/C12H14ClN/c1-9-4-5-10(11(13)8-9)12(2,3)6-7-14/h4-5,8H,6H2,1-3H3

Standard InChI Key:  WOAXMDCQROJZGH-UHFFFAOYSA-N

Associated Targets(non-human)

Gamma-aminobutyric acid receptor subunit alpha-6/beta-3/gamma-2 184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 207.70Molecular Weight (Monoisotopic): 207.0815AlogP: 3.84#Rotatable Bonds: 2
Polar Surface Area: 23.79Molecular Species: HBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.82CX LogD: 3.82
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.72Np Likeness Score: -1.04

References

1. Simeone X, Ernst M, Seidel T, Heider J, Enz D, Monticelli S, Vogel FD, Koniuszewski F, Langer T, Scholze P, Pace V, Miele M..  (2022)  Novel alpha6 preferring GABA-A receptor ligands based on loreclezole.,  244  [PMID:36279694] [10.1016/j.ejmech.2022.114780]

Source